Browse by Aston Author

2016

Skipworth, Richard J.E.; Stephens, Nathan A.; Johns, Neil; Guttridge, Denis C.; Tisdale, Michael J.; Baracos, Vickie E. and Glass, David J. (2016). Ken Fearon:obituary. Cell metabolism, 24 (6), pp. 765-766.

Mirza, Kamran A.; Luo, Menghua; Pereira, Suzette; Voss, Anne; Das, Tapas and Tisdale, Michael J. (2016). In vitro assessment of the combined effect of eicosapentaenoic acid, green tea extract and curcumin C3 on protein loss in C2C12 myotubes. In Vitro Cellular and Developmental Biology: Animal, 52 (8), 838–845.

2014

Mirza, Kamran A.; Pereira, Suzette L.; Voss, Anne C. and Tisdale, Michael J. (2014). Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia. Nutrition, 30 (7-8), pp. 807-813.

2012

Russell, Steven T. and Tisdale, Michael J. (2012). Role of β-adrenergic receptors in the oral activity of zinc-α2-glycoprotein (ZAG). Endocrinology, 153 (10), pp. 4696-4704.

Russell, Steven T. and Tisdale, Michael J. (2012). Role of β-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-α2-glycoprotien (ZAG). BBA - Molecular and Cell Biology of Lipids, 1821 (4), pp. 590-599.

2010

Russell, Steven T.; Siren, Pontus M.A.; Siren, Matti J. and Tisdale, Michael J. (2010). Mechanism of attenuation of protein loss in murine C2C12 myotubes by d-myo-inositol 1,2,6-triphosphate. Experimental Cell Research, 316 (2), pp. 286-295.

2009

Russell, Steven T. and Tisdale, Michael J. (2009). Mechanism of attenuation by β-hydroxy-β-methylbutyrate of muscle protein degradation induced by lipopolysaccharide. Molecular and Cellular Biochemistry, 330 (1-2), pp. 171-179.

Russell, Steve T.; Siren, P.M.A.; Siren, M.J. and Tisdale, Michael J. (2009). Attenuation of skeletal muscle atrophy in cancer cachexia by d-myo-inositol 1,2,6-triphosphate. Cancer Chemotherapy and Pharmacology, 64 (3), pp. 517-527.

Eley, Helen L.; McDonald, Pria S.; Russell, Steve T. and Tisdale, Michael J. (2009). Inhibition of activation of dsRNA-dependent protein kinase and tumour growth inhibition. Cancer Chemotherapy and Pharmacology, 63 (4), pp. 651-659.

Russell, Steve T.; Rajani, Seema; Dhadda, Raj S. and Tisdale, Michael J. (2009). Mechanism of induction of muscle protein loss by hyperglycaemia. Experimental Cell Research, 315 (1), pp. 16-25.

2008

Eley, Helen L.; Russell, Steve T and Tisdale, Michael J. (2008). Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by beta-hydroxy-beta-methylbutyrate. American Journal of Physiology, 295 (6), E1409-E1416.

Eley, Helen L.; Russell, Steve T. and Tisdale, Michael J. (2008). Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-alpha and angiotensin II by beta-hydroxy-beta-methylbutyrate. American Journal of Physiology, 295 (6), E1417-E1426.

Eley, H.L.; Russell, Steve T. and Tisdale, Michael J. (2008). Role of the dsRNA-dependent protein kinase (PKR) in the attenuation of protein loss from muscle by insulin and insulin-like growth factor-I (IGF-I). Molecular and Cellular Biochemistry, 313 (1-2), pp. 63-69.

Russell, Steve T.; Eley, Helen L.; Wyke, Stacey M. and Tisdale, Michael J. (2008). Involvement of phosphoinositide 3-kinase and Akt in the induction of muscle protein degradation by proteolysis-inducing factor. Biochemical Journal, 409 (Part 3), pp. 751-759.

Yano, Claudia L.; Ventrucci, Gislaine; Field, William N.; Tisdale, Michael J. and Gomes-Marcondes, Maria Cristina C. (2008). Metabolic and morphological alterations induced by proteolysis-inducing factor from Walker tumour-bearing rats in C2C12 myotubes. BMC Cancer, 8 (24), 24-.

2007

Todorov, Penio T.; Wyke, Stacey M. and Tisdale, Michael J. (2007). Identification and characterization of a membrane receptor for proteolysis-inducing factor on skeletal muscle. Cancer Research, 67 (23), pp. 11419-11427.

Eley, Helen L.; Russell, Steven T.; Baxter, Jeffrey H.; Mukerji, Pradip and Tisdale, Michael J. (2007). Signaling pathways initiated by β-hydroxy-β-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli. American Journal of Physiology, 293 (4), pp. 923-931.

Russell, Steve T.; Eley, Helen and Tisdale, Michael J. (2007). Mechanism of attenuation of angiotensin-II-induced protein degradation by insulin-like growth factor-I (IGF-I). Cellular Signalling, 19 (7), pp. 1583-1595.

Tisdale, Michael J. (2007). Letter to the editor: eicosapentaenoic acid containing nutritional supplements for the treatment of cancer cachexia:Eicosapentaenoic acid containing nutritional supplements for the treatment of cancer cachexia. Clinical Nutrition, 26 (1), pp. 161-162.

2006

Fearon, Kenneth C.H.; Barber, Matthew D.; Moses, Alastair G.; Ahmedzai, Sam H.; Taylor, Gillian S.; Tisdale, Michael J. and Murray, Gordon D. (2006). Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. Journal of clinical oncology, 24 (21), pp. 3401-3407.

2005

Chand, Anita; Wyke, Stacey M. and Tisdale, Michael J. (2005). Effect of cancer cachexia on the activity of tripeptidyl-peptidase II in skeletal muscle. Cancer Letters, 218 (2), pp. 215-222.

2004

Smith, Helen J.; Wyke, Stacey M. and Tisdale, Michael J. (2004). Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by β-hydroxy-β-methylbutyrate. Cancer Research, 64 (23), pp. 8731-8735.

Sanders, Paul M. and Tisdale, Michael J. (2004). Effect of zinc-alpha 2-glycoprotein (ZAG) on expression of uncoupling proteins in skeletal muscle and adipose tissue. Cancer Letters, 212 (1), pp. 71-81.

Smith, Helen J.; Greenberg, N.A. and Tisdale, Michael J. (2004). Effect of eicosapentaenoic acid, protein and amino acids on protein synthesis and degradation in skeletal muscle of cachectic mice. British Journal of Cancer, 91 (2), pp. 408-412.

Bing, Chen; Bao, Yi; Jenkins, John; Sanders, Paul; Manieri, Monia; Cinti, Saverio; Tisdale, Michael J. and Trayhurn, Paul (2004). Zinc-α2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proceedings of the National Academy of Sciences, 101 (8), pp. 2500-2505.

2003

Smith, Helen J. and Tisdale, Michael J. (2003). Signal transduction pathways involved in proteolysis-inducing factor induced proteasome expression in murine myotubes. British Journal of Cancer, 89 (9), pp. 1783-1788.

Fearon, K.C.H.; von Meyenfeldt, M.F.; Moses, A.G.W.; van Geenen, R.; Roy, A.; Gouma, D.J.; Giacosa, A.; Van Gossum, A.; Bauer, J.; Barber, M.D.; Aaronson, N.K.; Voss, A.C. and Tisdale, Michael J. (2003). Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia:A randomised double blind trial. Gut, 52 (10), pp. 1479-1486.

Whitehouse, A.S. and Tisdale, Michael J. (2003). Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-kappa B. British Journal of Cancer, 89 (6), pp. 1116-1122.

Whitehouse, A.S.; Khal, J. and Tisdale, Michael J. (2003). Induction of protein catabolism in myotubes by 15(S)-hydroxyeicosatetraenoic acid through increased expression of the ubiquitin-proteasome pathway. British Journal of Cancer, 89 (4), pp. 737-745.

Simpson, Julie; Forrester, Rebecca; Tisdale, Michael J.; Billington, David C. and Rathbone, Daniel L. (2003). Effect of catechol derivatives on cell growth and lipoxygenase activity. Bioorganic and Medicinal Chemistry Letters, 13 (15), pp. 2435-2439.

Wang, Zejing; Corey, Eva; Hass, G. Michael; Higano, Celestia S.; True, Lawrence D.; Wallace, David; Tisdale, Michael J. and Vessella, Robert L. (2003). Expression of the human cachexia-associated protein (HCAP) in prostate cancer and in a prostate cancer animal model of cachexia. International Journal of Cancer, 105 (1), pp. 123-129.

Tisdale, Michael J. (2003). The 'cancer cachectic factor'. Supportive care in cancer, 11 (2), pp. 73-78.

2002

Tisdale, Michael J. (2002). Cachexia in cancer patients. Nature Reviews: Cancer, 2 (11), pp. 862-871.

Gomez-Ambrosi, J.; Zabalegui, N.; Bing, C.; Tisdale, Michael J.; Trayhurn, P. and Williams, G. (2002). Weight loss in tumour-bearing mice is not associated with changes in resistin gene expression in white adipose tissue. Hormone and Metabolic Research, 34 (11-12), pp. 674-677.

Gomes-Marcondes, Maria Cristina C. and Tisdale, Michael J. (2002). Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress. Cancer Letters, 180 (1), pp. 69-74.

Gomes-Marcondes, Maria C.C.; Smith, Helen J.; Cooper, J.C. and Tisdale, Michael J. (2002). Development of an in-vitro model system to investigate the mechanism of muscle protein catabolism induced by proteolysis-inducing factor. British Journal of Cancer, 86 (10), pp. 1628-1633.

2001

Bing, C.; Taylor, S.; Tisdale, Michael J. and Williams, G. (2001). Cachexia in MAC16 adenocarcinoma:Suppression of hunger despite normal regulation of leptin, insulin and hypothalamic neuropeptide Y. Journal of Neurochemistry, 79 (5), pp. 1004-1012.

Whitehouse, A.S. and Tisdale, Michael J. (2001). Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation. Biochemical and Biophysical Research Communications, 285 (3), pp. 598-602.

Islam-Ali, B.; Khan, S.; Price, S.A. and Tisdale, Michael J. (2001). Modulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF). British Journal of Cancer, 85 (5), pp. 758-763.

Islam-Ali, B.S. and Tisdale, Michael J. (2001). Effect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradation. British Journal of Cancer, 84 (12), pp. 1648-1655.

Whitehouse, A.S.; Smith, Helen J.; Drake, J.L. and Tisdale, Michael J. (2001). Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid. Cancer Research, 61 (9), pp. 3604-3609.

Barber, Matthew D.; Fearon, Kenneth C.H.; Tisdale, Michael J.; McMillan, Donald C. and Ross, James A. (2001). Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutrition and Cancer, 40 (2), pp. 118-124.